LOUISE B HALBLEIB

Allopathic & Osteopathic Physicians|Family Medicine CUSTER, SD NPI 1780118448

General Payments — all program years on this page

$1,120.00

  • Category: General Payments
  • Program years: PY2020–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $351.67 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $351.6722

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2020 $11.751
2021 $227.1016
2022 $303.1518
2023 $226.3314
2024 $351.6722

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086115172 Bayer Healthcare Pharmaceuticals Inc. $18.02 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096581513 Novo Nordisk Inc $17.22 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1096928930 Novo Nordisk Inc $14.34 08/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097026431 Novo Nordisk Inc $16.81 01/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097613647 Novo Nordisk Inc $13.08 02/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101428880 E.R. Squibb & Sons, L.L.C. $15.69 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101428922 E.R. Squibb & Sons, L.L.C. $13.59 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111592930 Amgen Inc. $14.67 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111592932 Amgen Inc. $17.80 03/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111592934 Amgen Inc. $15.90 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111592936 Amgen Inc. $14.61 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111592938 Amgen Inc. $18.78 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111592940 Amgen Inc. $19.04 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111592942 Amgen Inc. $12.71 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114427874 Exact Sciences Corporation $15.83 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114427877 Exact Sciences Corporation $13.44 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117269537 Amgen Inc. $11.89 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117269539 Amgen Inc. $15.97 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131221891 PFIZER INC. $20.06 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135133836 Lilly USA, LLC $19.90 02/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135147892 Lilly USA, LLC $16.02 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135159438 Lilly USA, LLC $16.30 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.